Use of compounds for the manufacture of a Medicament to promote the regeneration of neurons or Neuritic outgrowths in the treatment of xerophthalmia and the decrease in corneal sensitivity after LASIK or other corneal surgeries when nerves are lesionad

摘要

Use of a therapeutically effective amount of a composition comprising at least a compound for the manufacture of a drug that promotes the regeneration of neurons or Neuritic outgrowths in the treatment of xerophthalmia in corneal nerve injuries.These disorders are a result of nerve injury to corneal after lasik and other Eye Surgery or trauma.The compounds used are selected from the group consisting of propentofylline, AIT 082 (neotrofina), Idebenone, Ono - 2506, CB - 1093, ns521 (1 - (Butyl) - 4 - (2 - oxo - 1 - benzimidazona), piperidine, eliprodil, sr57746a (Xaliproden hydrochloride) or similar the same pharmaceutically accepted Bles.